Saxenda vs Orforglipron
Editorial comparison of Saxenda (liraglutide) and Orforglipron (orforglipron). Same drug class context, trial-anchored data, no marketing claims.
Side-by-side
| Dimension | Saxenda | Orforglipron |
|---|---|---|
| Generic name | liraglutide | orforglipron |
| Manufacturer | Novo Nordisk | Eli Lilly |
| FDA approved | 2014 | 2026 |
| Mechanism | Single GLP-1 receptor agonist. Same mechanism family as semaglutide/Wegovy but shorter half-life (~13 hours) requiring daily dosing instead of weekly. | Same target as injectable GLP-1s — the GLP-1 receptor — but a non-peptide small-molecule structure. |
| Dosing | Titrated weekly: 0.6mg → 1.2mg → 1.8mg → 2.4mg → 3.0mg maintenance, all once daily. | Once-daily oral tablet, titrated upward over several weeks to manage GI side effects. No fasting or water-timing restrictions (unlike Rybelsus). |
| Cost | List price ~$1,350/month. Cash-pay similar. Insurance coverage variable. Cheaper coupons through Novo Nordisk savings card programs. | $149/month via LillyDirect cash-pay at launch — meaningfully below branded injectable list prices. |
| Pivotal trial result | 8.4% mean body-weight reduction at 56 weeks (3.0 mg dose) | ~14-15% mean body-weight reduction in Phase 3 (highest dose) |
Full Saxenda review →
FDA-approved daily injectable liraglutide for chronic weight management. Older-generation GLP-1, daily dosing.
Full Orforglipron review →
First once-daily oral non-peptide GLP-1. Brand-only, launching via LillyDirect at $149/month. No injection, no compounded versions.
Frequently asked
Is Saxenda or Orforglipron more effective?+
In their pivotal trials, Saxenda reported 8.4% mean body-weight reduction at 56 weeks (3.0 mg dose), while Orforglipron reported ~14-15% mean body-weight reduction in Phase 3 (highest dose). Head-to-head results vary by patient profile, dose tolerated, and adherence — these trial numbers describe averages, not what every individual experiences.
How do Saxenda and Orforglipron compare on cost?+
Saxenda: List price ~$1,350/month. Cash-pay similar. Insurance coverage variable. Cheaper coupons through Novo Nordisk savings card programs. Orforglipron: $149/month via LillyDirect cash-pay at launch — meaningfully below branded injectable list prices. Insurance coverage will expand through 2026-2027 as formularies add it. Real out-of-pocket depends on insurance formulary tier, manufacturer savings programs, and whether a direct-pay channel is available.
Can I switch from Saxenda to Orforglipron?+
Switching between brand-name treatments in the same drug class is common, but the conversion is not always 1:1. Discuss the switch with your prescriber — they'll usually re-titrate dosing rather than substitute equivalent strengths directly.
Are Saxenda and Orforglipron the same drug?+
No. Saxenda (liraglutide) and Orforglipron (orforglipron) are distinct medications from Novo Nordisk and Eli Lilly respectively. They may share a drug class or mechanism but differ in active ingredient, dosing, and approved use.